Skip to main content
Clinical Trials/CTRI/2019/04/018752
CTRI/2019/04/018752
Suspended
Phase 2

A randomized controlled three arm clinical trial on the of effectiveness Mudakku Vatha Ilagam (MVI) and Varmam Therapy in Midlife population afflicted by Azhal Keel Vayu (AKV Knee-Osteoarthritis).

Central Council for Research in Siddha0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Central Council for Research in Siddha
Status
Suspended
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Central Council for Research in Siddha

Eligibility Criteria

Inclusion Criteria

  • 1\. Sex – Both sex
  • 2\. Patients with Primary Osteoarthritis \- knee joints (single or both knees).
  • 3\. Swelling in the Knee Joints
  • 4\. Joint stiffness
  • 5\. Restricted movements of joints.
  • 6\. Crepitus of joints.
  • 7\.Patients with WOMAC Score \= 25 \= 72

Exclusion Criteria

  • 1\.Age less than 40 years or more than 60 years.
  • 2\.Patients with Diabetes/Hepatic failure/Renal failure.
  • 3\.History of bony or soft tissue injury to knee joint/ surgical interventions
  • 4\.Patients having Rheumatoid arthritis, Gout, Viral fever (Chikungunya) and Psoriatic arthritis.
  • 5\.Patients who are taking any form of steroids.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
The Effect of Applied Muscle Tension On Vasovagal Reactions Study
ACTRN12617000486325Australian Red Cross Blood Service750
Withdrawn
Not Applicable
Better Drive 2: Effect of computerised cognitive training and on-road skills training on driving safety in older adultsAgeing associated driving impairmentInjuries and Accidents - Other injuries and accidentsPhysical Medicine / Rehabilitation - Occupational therapyNeurological - Dementias
ACTRN12618000405213The Australian National University126
Completed
Phase 3
A Phase III randomized controlled clinical trial of CARBOPLATIN and PACLITAXEL(OR GEMCITABINE) alone or in combination with BEVACIZUMAB (NSC #704865, IND #7921) followed by BEVACIZUMAB and secondary cytoredutive surgery in platinum sensitive, recurrent ovarian, peritoneal primary and fallopian tube cancer.PLATINUM-SENSITIVE, RECURRENT OVARIAN, PERITONEAL PRIMARY AND FALLOPIAN TUBE CANCER
JPRN-UMIN000003682Gynecologic Oncology Group1,050
Active, not recruiting
Not Applicable
COIN A three-arm randomised controlled trial comparing either COntinous chemotherapy plus cetuximab or INtermittent chemotherapy with standard coninuous palliative combination chemotherapy with oxaliplatin and a fluoropyrimidine in first line treatment of metastatic colorectal cancer - COI
EUCTR2004-002951-16-IEMedical Research Council2,421
Active, not recruiting
Phase 1
Cataract surgery and inflammation – the role for preoperative NSAIDs (pre-CIN)
EUCTR2020-003407-34-NOOslo University Hospital200